Expression of IGF-1, IGF-1 receptor and TGF-β following balloon angioplasty in atherosclerotic and normal rabbit iliac arteries: An immunocytochemical study

Regulatory Peptides

Volumn 79, Issue 1, 1999, Pages 47-53

  Grant, Maria B ^a   Wargovich, Thomas J ^a   Bush, David M ^a   Player, Denifield W ^a   Caballero, Sergio ^a   Foegh, Marie ^b   Spoerri, Polyxenie E ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Growth factors; Myointimal hyperplasia; Restenosis

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; ILIAC ARTERY; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RESTENOSIS; SMOOTH MUSCLE FIBER;

ANGIOPLASTY, BALLOON; ANIMALS; ARTERIOSCLEROSIS; ILIAC ARTERY; INSULIN-LIKE GROWTH FACTOR I; RABBITS; RECEPTOR, IGF TYPE 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0032897785     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(98)00027-5     Document Type: Article

References (22)

1. Topol EJ, Caveat I. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. New Engl J Med 1993;329:221-7.
2. Schwartz RS, Holmes DRJ, Topol EJ. The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992;20:1284-93.
3. Raines E, Ross R. Mechanisms of plaque formation: cellular changes and possible role of growth-regulatory molecules. Atheroscler Rev 1991;23:143-52.
4. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor 1 is increased in human vascular restenosis lesions. J Clin Invest 1992;90:1882-992.
5. Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, Pepine CJ. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells: A potential treatment for restenosis. Circulation 1994;89:1511-7.
6. Banskota NK, Taub R, Zellner K, King GL. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protoncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol 1989;3:1183-90.
7. Grant MB, Wargovich TJ, Ellis EA, Tarnuzzer R, Caballero S, Estes K, Rossing M, Spoerri PE, Pepine C. Expression of IGF-1, IGF-1 receptor and IGF binding proteins -1, -2, -3, -4, and -5 in human atherectomy specimens. Regul Pept 1996;67:137-44.
8. Rosenfeld ME, Tsukada T, Gown AM, Ross M. Fatty streak initiation in Watanebe heritable hyperlipemic and comparably hypercholesterlemic fat fed rabbits. Atherosclerosis 1987;7:9-23.
9. Bendayan M. Protein A-gold electron microscopic immunocytochemistry: methods, applications, and limitations. J Electron Microsc Techn 1984;1:242-70.
10. Clemmons DR. IGF binding proteins: regulation of cellular actions. Growth Regul 1992;2:80-7.
11. Grant MB. Insulin-like growth factors in blood vessels. Curr Opin Endocrinol Diabetes 1996;3:335-45.
12. Clemmons DR. Interaction of circulating cell-derived and plasma growth factors in stimulating cultured smooth muscle cell replication. J Cell Physiol 1984;121:425-30.
13. Klagsburn M, Edelman ER. Biological and biochemical properties of fibroblast growth factors: implications for the pathogenesis of restenosis. Atherosclerosis 1989;9:269-78.
14. Merimee TJ, Fineberg SE, McKusick VA, Hall J. Diabetes mellitus and sexual ateliotic dwarfism: a comparative study. J Clin Invest 1970;49:1096-2102.
15. Tiell ML, Stemerman MB, Spaet TH. The influence of the pituitary on arterial intimal proliferation in the rat. Circ Res 1978;42:644-9.
16. Lundergan CF, Foegh ML, Ramwell PW. Peptide inhibition of myointimal proliferation by angiopeptin, a somatostatin analogue. J Am Coll Cardiol 1991;17:132B-6B.
17. Santoian ED, Schneider JE, Gravanis MB, Foegh M, Tarazona N, Cipolla FGD, King S. Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries. Circulation 1993;88:11-4.
18. Hong MK, Kent KM, Mehran R, Mintz GS, Tio FO, Foegh M, Wong SC, Cathapermal SS, Leon MB. Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model. Circulation 1997;95:449-54.
19. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor (TGF-beta) on endothelial cell growth correlate with phenotypes of TGF-beta binding sites. Exp Cell Res 1990;191:299-304.
20. Bobik A, Campbell JH. Vascular derived growth factors: cell biology, pathophysiology and pharmacology. Pharmacol Rev 1993;45:1-42.
21. Sato Y, Okada F, Abe M, Seguchi T, Kuwano M, Sato S, Furuya A, Hanai N, Tamaoki T. The mechanism for the activation of the latent TGF-β during co-culture of endothelial cells and smooth muscle cells: cell type specific targeting of latent TGF-β to smooth muscle cells. J Cell Biol 1993;123:1249-54.
22. Merilees MJ, Scott L. Endothelial cell stimulation of smooth muscle cells: cell-type specific targeting of latent TGF-β to smooth muscle cells. J Cell Biol 1993;123:1249-54.